The news of the financial industry on September 30 This evening's important announcement is a sneak peek - Tianfeng Securities intends to transfer 9.58% of the shares of Hengtai Securities for 1.8 billion yuan, Zhou Yong, the actual controller of Saiwei Intelligent and chairman of the board, is investigated and retained for suspected bribery, and the net profit of Dongfang Electric Heating in the first three quarters of the year increased by 183%-195% year-on-year...
【Major Events】
Saiwei Intelligent (300044) announced on the evening of September 30 that the company recently received a notice from the family of Zhou Yong, the actual controller and chairman of the company, that according to the "Lien Notice" of the Quanjiao County Supervision Commission of Chuzhou City, Anhui Province, Zhou Yong was investigated for suspected bribery and took lien measures. In addition, the company signed a total of 205 million yuan in new contracts in the third quarter.
Ningde Times: Guohong Group intends to increase the capital of Sichuan Times, a wholly-owned subsidiary of the company
Ningde Times (300750) announced on the evening of September 30 that Luoyang Guohong Investment Holding Group Co., Ltd. intends to increase the capital of Sichuan Times New Energy Technology Co., Ltd., a wholly-owned subsidiary of the company, with its 100% equity interest in Luoyang Mining Group Co., Ltd. After the completion of the transaction, Luo Mining Group will become a wholly-owned subsidiary of Sichuan Times, and Sichuan Times will indirectly hold 24.68% of the shares of Luoyang Molybdenum through Luo Mining Group, becoming the second largest indirect shareholder of Luoyang Molybdenum Industry. The Company has no intention of seeking a controlling interest in Luoyang Molybdenum.
Watson Biologics: The new coronavirus mRNA vaccine has been authorized for emergency use in Indonesia
Watson Biologics (300142) announced on the evening of September 30 that the new coronavirus mRNA vaccine (SARS-CoV-2 mRNA Vaccine, trade name: Woaikexin/AWcorna) developed and produced by the company and its subsidiary Yuxi Watson Bio has obtained an emergency use authorization approved by the Indonesian State Food and Drug Administration. This product is the first new crown mRNA vaccine independently developed by mainland China to be approved for overseas marketing, and it is also the only new crown mRNA vaccine in the world that has passed halal certification.
Dongfang Electric Heating: Net profit in the first three quarters increased by 183%-195% year-on-year
Dongfang Electric Heating (300217) released a performance forecast on the evening of September 30, and it is expected that the net profit in the first three quarters of 2022 will be 230 million yuan - 240 million yuan, an increase of 182.98% - 195.25% year-on-year. During the reporting period, the polysilicon industry continued to be in a high-prosperity investment cycle; The production and sales of new energy vehicles continue to maintain rapid growth. Affected by this, during the reporting period, the company's new energy equipment business and PTC electric heater business for new energy vehicles achieved rapid growth year-on-year.
Shenzhen Expressway: Plans to invest in the Mechanical and Dutch High-Speed Reconstruction and Expansion Project
Shenzhen Expressway (600548) announced on the evening of September 30 that the company intends to invest in the reconstruction and expansion project of the He'ao to Shenzhen Airport section of the Shenyang-Haikou Expressway, with a total investment of about 43.29 billion yuan, and the company's investment in the project is about 12.987 billion yuan.
Huayang shares: produced by Sun Company's sodium ion battery cell production line
Huayang Co., Ltd. (600348) announced on the evening of September 30 that the installation and commissioning of the sodium-ion battery cell production line equipment invested and built by the company's wholly-owned grandson company, Shanxi Hua Na Core Energy Technology Co., Ltd., has been completed, and the company held a sodium-ion battery cell production line production line production ceremony in the high-end manufacturing industrial park of Yangquan High-tech Zone on the same day.
Tianfeng Securities: Proposed to transfer 9.58% of the shares of Hengtai Securities for 1.8 billion yuan
Tianfeng Securities (601162) announced on the evening of September 30 that the company intends to transfer 249 million shares of the domestic shares of Hengtai Securities Co., Ltd. held by Beijing Huarong Comprehensive Investment Co., Ltd., accounting for 9.5754% of the total shares of Hengtai Securities, with a total transaction price of 1.8 billion yuan and a transfer price of about 7.22 yuan per share.
【M&A and reorganization】
Yong'an Forestry: Plans to raise no more than 300 million yuan of indirect controlling shareholders fully subscribed
Yong'an Forestry (000663) announced on the evening of September 30 that the company intends to raise no more than 300 million yuan in non-public issuance of A-share shares for the Baoding biomass energy recycling project, the Xingtai biomass energy recycling project, and the biomass fermentation microbial research and development center project. Zhonglin Group, the Company's indirect controlling shareholder, will subscribe for all the shares in the non-public offering in cash.
Lingyizhizhuo: Intends to issue GDR overseas and list on the London Stock Exchange
Ling Yizhi Manufacturing (002600) announced on the evening of September 30 that the company intends to issue Global Depository Receipts ("GDR") overseas and list on the London Stock Exchange.
Letong Shares: Intends to continue to promote asset restructuring
Letong Co., Ltd. (002319) announced on the evening of September 30 that the company had previously announced that the company issued shares and paid cash to purchase 100% of the equity of Zhejiang Qichen Technology Co., Ltd., as well as the purchase of 45% of the equity of Hunan Nuclear Sanli Technology Engineering Co., Ltd. and the raising of supporting funds and related party transactions, which were not approved by the Mergers and Acquisitions and Restructuring Committee of the CSRC. In view of the fact that the implementation of the company's asset restructuring plan will help enhance the core competitiveness of the company's operation, improve asset quality, improve financial situation and enhance sustained profitability, the company decided to continue to promote the asset restructuring matter.
Hepalink: Plans to issue corporate bonds of not more than 1 billion yuan to professional investors
Hepalink (002399) announced on the evening of September 30 that the company intends to publicly issue corporate bonds to professional investors, with an issue size of no more than 1 billion yuan, which is intended to be used to repay the company's debt, adjust the debt structure, and supplement working capital.
Huaqi Environmental Protection: The restructuring plan is released The actual controller intends to become the Ma'anshan Municipal Government
Huaqi Environmental Protection (300929) disclosed on the evening of September 30 that the company intends to purchase 50% of the equity of Halo Jiangdong and 51% of the equity of Jiangdong China Railway held by Jiangdong City Investment by issuing shares, and the transaction price has not yet been determined. At the same time, the company intends to issue shares to Jiangdong Holdings to raise no more than 200 million yuan. Halo Jiangdong is mainly engaged in waste incineration power generation, kitchen waste treatment and other businesses, and Jiangdong Zhongtie is mainly engaged in sewage treatment business. After the completion of this transaction, the controlling shareholder of the company will become Jiangdong Holdings, and the actual controller will become the Ma'anshan Municipal Government. The company will become a listing platform for the energy-saving and environmental protection industry of Jiangdong Holdings, a state-owned enterprise in Ma'anshan City.
Hengdian Film & Television: Termination of the joint acquisition of 100% equity interest in Shanghai Xingyi
Hengdian Film and Television (603103) announced on the evening of September 30 that the company and its affiliates planned to jointly acquire 100% of the equity of Shanghai Xingyi Cinema Management Co., Ltd. by paying cash, of which the company intends to purchase about 70% of the equity of Shanghai Xingyi. As the parties to the transaction ultimately failed to agree on some of the core terms related to the transaction, the Company decided to terminate the planning of the material asset restructuring.
Jereh Shares: Planning to issue GDR overseas and list on the SIX Swiss Exchange
Jereh (002353) announced on the evening of September 30 that in order to promote the further implementation of the dual main business strategy of "oil and gas industry" and "new energy industry" and layout overseas markets, the company plans to issue global depositary receipts ("GDR") overseas and list on the Swiss Stock Exchange.
Yellow River Whirlwind: Termination of the 2022 non-public offering of shares
Yellow River Whirlwind (600172) announced on the evening of September 30 that in view of the many changes in industry conditions, market environment and capital market and other factors, the company intends to terminate the 2022 non-public issuance of A-share shares and apply to the CSRC to withdraw the application documents.
Nanning Sugar: Terminate the planning of major asset replacement matters
Nanning Sugar (000911) announced on the evening of September 30 that the company had previously announced that it intended to exchange assets with Guangxi Rural Investment Group Co., Ltd. and Nanning Luhua Investment Co., Ltd., and that the assets to be placed in the company were 100% of the equity of Guangxi Boxuan Food Co., Ltd., and the assets to be disposed of were 100% of the equity of Nanning Xiangshan Sugar Co., Ltd. In view of the fact that Guangxi Boxuan Food Co., Ltd. has not yet fully met the conditions for injection, after careful study, the company has decided to terminate the planning of this major asset replacement.
【Increase or decrease in holdings】
Zhende Medical: Plans to repurchase the company's shares for 75 million yuan to 150 million yuan
Zhende Medical (603301) announced on the evening of September 30 that it intends to repurchase the company's shares for 75 million yuan to 150 million yuan, and the repurchase price will not exceed 60 yuan per share. The repurchased shares will be used to implement the ESOP. Zhende Medical also disclosed the draft of the second phase of the employee stock ownership plan, and the source of shares in the employee stock ownership plan is the shares repurchased by the company, and the total number of shares does not exceed 2.4 million shares.
Zhenhua New Material: Shareholders intend to reduce their holdings of no more than 8% of the company's shares in total
Zhenhua New Materials (688707) announced on the evening of September 30 that the shareholders of SDIC Venture Fund, which holds 5.37% of the shares, Xin Tianyu Growth, which holds 5.67%, and Xin Tianyu, a shareholder of 2.26%, intend to reduce their holdings of no more than 8% of the company's shares in total. Xin Tianyu grows up and Xin Tianyu Phase VI is a consistent actor.
Youxunda: Huacheng Shengda intends to reduce its shareholding in the company by no more than 4.2%.
On the evening of September 30, Youxunda (300514) announced that Yunnan Huacheng Shengda Enterprise Management Co., Ltd., a specific shareholder of the company holding 9.61% of the shares, plans to reduce its shareholding in the company by no more than 8.4035 million shares (accounting for 4.2% of the company's total share capital) by means of centralized bidding or block trading.
Silk Road Vision: The actual controller intends to reduce the company's shares by no more than 3%.
Silk Road Vision (300556) announced on the evening of September 30 that Li Mengdi, the actual controller, chairman and president of the company, intends to reduce the total number of shares of the company within three months through centralized bidding and block trading, etc. to reduce the total number of shares of the company by not more than 3.5859 million shares (accounting for 3% of the total share capital of the company).
Seli Medical: The controlling shareholder intends to reduce its shareholding in the company by no more than 3%.
Seli Medical (603716) announced on the evening of September 30 that Saihai Technology, the company's controlling shareholder, intends to reduce its shareholding in the company by no more than 3%.
Wanhe Electric: The indirect controlling shareholder intends to reduce its shareholding in the company by no more than 2%.
Wanhe Electric (002543) announced on the evening of September 30 that Guangdong Wanhe Group Co., Ltd., the company's indirect controlling shareholder, plans to reduce its shareholding in the company by no more than 14.872 million shares (that is, no more than 2% of the company's total share capital) within 6 months after 15 trading days.
Xinbo shares: Wuhu Yida and Huangshan Yida intend to reduce their holdings by no more than 2% of the shares in total
Xinbo Co., Ltd. (003038) announced on the evening of September 30 that Wuhu Gaoxin Yida SME Venture Capital Fund and Huangshan Gaoxin Yida Xin'anjiang Specialized New Venture Capital Fund, shareholders of the company holding a total of 6.81% of the shares, plan to reduce the total number of shares in the company within 6 months after 15 trading days, through centralized auction transactions, to no more than 2% of the company's total share capital. They are consistent actors with the same firm as the executive partner.
Gan&Lee Pharmaceutical: Minghua Innovation intends to reduce its shareholding in the company by no more than 2%.
Gan&Lee Pharmaceutical (603087) announced on the evening of September 30 that Minghua Innovation Technology Investment (Hong Kong) Co., Ltd., a shareholder holding 12.03% of the shares, intends to reduce the total number of shares in the company by means of a centralized auction transaction to not exceed 11.2308 million shares, that is, not more than 2% of the company's total share capital.
Ming Microelectronics: Shareholders intend to reduce their holdings of no more than 1.94% of the company's shares
Ming Microelectronics (688699) announced on the evening of September 30 that Huang Xueliang, a shareholder of the company holding 8.66% of the shares, intends to transfer no more than 3.36% of the company's shares to the private fund products in which he holds 100% of the shares through a block transaction, and the share change is an internal transfer between shareholders Huang Xueliang and his co-actors. In addition, Huang Xueliang intends to reduce his shareholding in the company by means of a collective auction of not more than 1.94%.
Rockchip: Shareholders intend to reduce their shareholding in the company by no more than 2%.
Rockchip (603893) announced on the evening of September 30 that Shanghai Wuyuefeng Integrated Circuit Equity Investment Partnership (Limited Partnership) and Beijing Wuyuefeng Yihe High-tech Industry Investment Partnership (Limited Partnership) plan to reduce their total shares in the company by means of a centralized bidding to no more than 8.3472 million shares, that is, not more than 2% of the total number of shares in the company. The two shareholders acted in concert.
Besdaq: Executives intend to reduce their stake in the company by no more than 0.81%.
On the evening of September 30, 300822 announced that Li Haijian, a director and secretary of the board of directors holding 3.43% of the company, plans to reduce the total number of shares in the company by means of centralized bidding and block trading, which does not exceed 1.3 million shares (accounting for 0.81% of the company's total share capital).
【Other matters】
Tuopu Group: Plans to invest no less than 2 billion yuan in the construction of new energy vehicle core parts base
Tuopu Group (601689) announced on the evening of September 30 that the company signed an investment agreement with the Administrative Committee of Huzhou Changxing Economic and Technological Development Zone. The company plans to invest no less than 2 billion yuan in Changxing Economic and Technological Development Zone, with a planned land scale of about 200 mu and build a production base for core components of new energy vehicles. The base mainly produces key products for new energy vehicles such as lightweight chassis, lightweight car body, interior functional parts, and automotive electronics.
Jingneng Power: The 1.5 million kilowatts large-scale wind power photovoltaic base project in Wulanchabu was approved
Jingneng Power (600578) announced on the evening of September 30 that the 1.5 million kilowatts of Wulanchabu "integrated wind, light, fire, hydrogen storage" large-scale wind power photovoltaic base project was approved. The total investment of the project is 9.179 billion yuan, the project capital accounts for 20% of the total investment, and the rest of the funds are solved by financing.
Ningbo Construction Engineering: Wholly-owned subsidiary won the bid for a project of 1.056 billion yuan
Ningbo Construction Engineering (601789) announced on the evening of September 30 that its wholly-owned subsidiary won the bid for the renovation of dangerous old houses in Ruian Yongshengmen Future Community Garden Road West and Huabin Road plots, Yongshengmen Community Wayao Road, Wayao Bridge and Xihenghe Barge Project, and Yongshengmen Community Corridor and Water Platform Project. The winning bid price is 1.056 billion yuan and the construction period is 910 days.
Shanghai Yizhong: Clinical trial of paclitaxel polymer micelle drug for injection was approved
Shanghai Yizhong (688091) announced on the evening of September 30 that the company's core product paclitaxel polymer micelles for injection have obtained the "Drug Clinical Trial Approval Notice" and agreed to carry out clinical trials for new indications for breast cancer. As the cornerstone drug of chemotherapy for the treatment of oncological diseases, paclitaxel is one of the most effective anti-tumor drugs on the market at present, with a wide range of indications and a rich clinical use plan. As an innovative dosage form of paclitaxel, paclitaxel micelle belongs to the national major new drug creation project.
Guangji Pharmaceutical: Holding subsidiary completed equipment overhaul and resumed production on October 7
Guangji Pharmaceutical (000952) announced on the evening of September 30 that its holding subsidiary, Guangji Pharmaceutical (Mengzhou) Co., Ltd., has now completed the maintenance of related equipment and facilities, and Mengzhou Company has decided to resume production on October 7.
Zhaolong Interconnection: Plans to invest 112 million yuan in the construction of data cable connection component projects
Zhaolong Interconnection (300913) announced on the evening of September 30 that the company intends to invest in the construction of data cable connection components green intelligent manufacturing and intelligent logistics project in Shilin Industrial Zone, Xinshi Town, Deqing County, Zhejiang Province, with a total investment of 112 million yuan and an expected construction period of 12 months.
Burson-Marsteller Biologics: The subsidiary obtained the drug registration certificate of Acarbose tablets
Boya Bio (300294) announced on the evening of September 30 that recently, Guizhou Tian'an Pharmaceutical Co., Ltd., a holding subsidiary, received the "Drug Registration Certificate" of acarbose tablets issued by the State Food and Drug Administration and approved the production of the drug. The drug is used in combination with diet control for type 2 diabetes; Lowers postprandial blood glucose in people with low glucose tolerance.
Danghong Technology: Selected as a national specialized new "Little Giant" enterprise
When Hong Technology (688039) announced on the evening of September 30, the company was identified as the fourth batch of national specialized new "Little Giant" enterprise title, valid for three years.
Changshan Pharmaceutical: Enoxaparin sodium injection obtained the drug registration certificate of Turkmenistan
Changshan Pharmaceutical (300255) announced on the evening of September 30 that the company's drug Enoxaparin sodium injection obtained the drug registration certificate issued by the Ministry of Health and Medical Industry of Turkmenistan. At present, the company's overseas sales revenue of heparin preparation products accounts for a low proportion of the company's total operating income.
Jilin Aodong: The subsidiary obtained 11 Chinese medicine formula granules listing filing certificates
Jilin Aodong (000623) announced on the evening of September 30 that recently, Jilin Aodong Yanbian Pharmaceutical, a holding subsidiary, obtained 11 "Listing Records for Chinese Medicine Formula Granules". Up to now, Yanbian Pharmaceutical has obtained a total of 193 "Listing Records for Chinese Medicine Formula Granules".
ST Basis: Apply for cancellation of stock trading and other risk warnings
ST Foundation (600515) announced on the evening of September 30 that the relevant circumstances such as capital occupation and undisclosed guarantee involved in the company's "Self-Inspection Report" and the "Administrative Penalty Decision" of the China Securities Regulatory Commission have been eliminated. The Company submits to the SSE other risk warning applications for the cancellation of the Company's stock trading.
Nanshan Holdings: A subsidiary of 1.7355 billion yuan bid for a residential land in Minhang, Shanghai
Nanshan Holdings (002314) announced on the evening of September 30 that recently, the company's wholly-owned subsidiaries Suzhou Nanshan Xincheng Real Estate Development Co., Ltd. and Shennan (Wuxi) Vehicle Networking Co., Ltd. formed a bidding consortium to bid for the right to use state-owned construction land in the 53-01 plot of MHPO-1403 unit MHPO-1403 in Huacao Town, Minhang District, Shanghai for 1.7355 billion yuan. The plot is residential land.
Haizheng Pharmaceutical: Daptomycin for injection passed the consistency evaluation of generic drugs
Haizheng Pharmaceutical (600267) announced on the evening of September 30 that the company's daptomycin for drug injection passed the consistency evaluation of generic drugs. Daptomycin for injection is suitable for the treatment of complex skin and skin structure infections (cSSSI) in adults and pediatric patients (1 to 17 years).
Wasion Information: Won the bid for the 2012.68 million yuan State Grid Fujian power procurement project
Wasion Information (688100) announced on the evening of September 30 that the company won the bid for the second distribution network material agreement inventory public bidding procurement project of State Grid Fujian Electric Power Co., Ltd. in 2022, with a winning bid amount of 20.1268 million yuan, accounting for 1.1% of the company's total operating income in 2021.
Shenhua, China: Completely withdrew from the Watermark coal mine project in Australia
China Shenhua (601088) announced on the evening of September 30 that it had received notice from the Australian Securities and Investment Commission that Shenhua Watermark Coal Mine Co., Ltd., a wholly-owned subsidiary of the company, had completed the deregistration. The company fully withdrew from the Watermark Coal Mine Project in Australia. In 2008, the company won the bid for the Watermark coalfield exploration license project, and set up a wholly-owned subsidiary as the main body of project development in the same year. In recent years, because the coal mine project is no longer in line with the local trend of climate change and energy structure adjustment, after comprehensive analysis and evaluation, the company decided to gradually withdraw from the Watermark project.
Changshu Bank: Vice President Bao Jian resigned due to job transfer
Changshu Bank (601128) announced on the evening of September 30 that Bao Jian resigned as vice president of the bank due to job transfer.
COSCO SHIPPING Holdings: Plans to acquire the equity of COSCO SHIPPING Supply Chain Company for RMB1.217 billion
COSCO SHIPPING (601919) announced on the evening of September 30 that COSCO SHIPPING Logistics intends to transfer about 13.46% of the equity of COSCO SHIPPING Logistics Supply Chain Co., Ltd. to COSCO SHIPPING Consolidation, a wholly-owned subsidiary of the company, for a transaction price of 1.217 billion yuan. COSCO SHIPPING Logistics Supply Chain Co., Ltd. intends to introduce strategic investors and implement employee shareholding through capital increase and share expansion, and after the completion of the capital increase and employee shareholding, COSCO SHIPPING Consolidated holds 7% of the equity of COSCO SHIPPING Logistics Supply Chain Co., Ltd. COSCO SHIPPING Logistics is a wholly-owned subsidiary of COSCO SHIPPING Control's indirect controlling shareholder, China COSCO SHIPPING.
Sanda Film: Xuchang fundraising project project completed
Sanda Membrane (688101) announced on the evening of September 30 that one of the company's fundraising projects, "Xuchang Jian'an District Sewage Treatment Plant Upgrading and Expansion Project Based on High-performance Film Application", has been completed and has the conditions for production. Water investment and operation business is one of the company's main businesses, Xuchang fundraising project completion is conducive to improving the company's market share.
Shenzhen Sanda A: China Electronics Cloud, a subsidiary, intends to introduce a capital increase and implement mixed reform
Shenzhen Sanda A (000032) announced on the evening of September 30 that its subsidiary, CLP Cloud Digital Intelligence Technology Co., Ltd. (hereinafter referred to as "China Electronics Cloud Company"), intends to introduce strategic investors to increase capital and implement mixed reform in accordance with the "science and technology reform demonstration action" policy, and the amount of external strategic investors to increase funds corresponds to the shareholding ratio after the capital increase is not higher than 8%. The capital increase project of China Electronics Cloud Company will be pre-listed on the Beijing Equity Exchange. After completing the approval procedures of the units entitled to approve and the internal review procedures of the company, the official listing will be implemented.
Design Institute: Intends to participate in the subscription of Anhui Traffic Control Yanjiang Expressway public offering REITs
The General Institute of Design (603357) announced on the evening of September 30 that Anhui Transportation Holding Group Co., Ltd., the controlling shareholder of the company, as the original owner, intends to issue infrastructure public REITs funds through CICC Fund Management Co., Ltd. with the Wuhu (Zhanghan) to Anqing (Dadukou) section of the Yanjiang Expressway as an infrastructure asset. The Company intends to subscribe as a strategic investor for the Fund's shares, subject to a cap of RMB300 million.
Tianji Shares: The subsidiary company obtains the approval of the project safety conditions
Tianji Co., Ltd. (002759) announced on the evening of September 30 that the new project submitted by its subsidiary Jiangsu Terry Lianteng Material Technology Co., Ltd. with an annual output of 30,000 tons of lithium hexafluorophosphate, 6,000 tons of high-purity lithium fluoride, 20% aqueous solution of potassium chloride 17,000 tons, 28,000 tons of solid calcium fluoride and 313,000 tons of by-product hydrochloric acid 20% and by-product hydrofluoric acid 30% 23,000 tons was approved by the project safety conditions.
Rip Biologics: Obtained a new veterinary drug registration certificate
Ruipu Bio (300119) announced on the evening of September 30 that Ruipu (Tianjin) Biopharmaceutical Co., Ltd., a wholly-owned subsidiary, recently obtained the "New Veterinary Drug Registration Certificate" of ivermectin praziquantel chewable tablets and andrographolide sulfonate injection issued by the Ministry of Agriculture and Rural Affairs. Ivermectin praziquantel chewable tablets broad spectrum compound new preparation for the treatment of canine nematode infection and tapeworm infection, while clinically having a synergistic effect on dogs often suffering from in vitro parasites. Andrographolide sulfonate injection is used for adjuvant therapy of Mycoplasma porcine pneumonia.
Metro design: pre-won the bid for an intercity design project of 1.185 billion yuan
Metro Design (003013) announced on the evening of September 30 that the company announced that it was the first winning candidate for the "Foshan Intercity Design and General Contracting Management Project from Guangzhou to Dongguan", with a planned bid amount (bidding price) of 1.185 billion yuan, accounting for 49.77% of the company's annual operating income in 2021.
Daqian Ecology: There are significant uncertainties in the change of control of the company
Daqian Ecology (603955) announced on the evening of September 30 that the company previously announced that the controlling shareholder, Daqian Investment, intends to transfer 19.78% of the company's shares to Suyuan Technology, which will lead to a change in the control of the company. In view of the extensive concerns and doubts of the relevant parties on the issues of the acquirer's legal qualifications, credit standing, performance ability, etc., the suitability of the acquirer is an important condition for the transaction, and there is significant uncertainty as to whether the transfer of control can be smoothly advanced.
Hong Tao shares: terminate the proposed change of the actual controller
Hongtao Co., Ltd. (002325) announced on the evening of September 30 that after the signing of the Share Transfer Intention Agreement, Liu Nianxin, the controlling shareholder of the company, and Hubei United Investment Investment and Development Co., Ltd. conducted full communication, and the two parties finally reached a consensus and decided to terminate the acquisition, terminate the Share Transfer Intention Agreement, and terminate the proposed changes of the controlling shareholder and the actual controller.
Tianfeng Securities: Lianfa Investment Group will transfer 5.99% of the company's shares to Hongtai Group
Tianfeng Securities (601162) announced on the evening of September 30 that the company's shareholder, Lianfa Investment Group, signed a share transfer agreement with Lianhe Investment Group and Hongtai Group. Lianfa Investment Group intends to transfer 5.99% of the company's shares to Hongtai Group for a transfer price of 1.677 billion yuan. After this equity change, Hongtai Group will directly hold 13.84% of the company's shares, becoming the company's largest shareholder; Lianfa Investment Group will no longer hold the company's shares. The company did not have a controlling shareholder and a actual controller before the change of equity, and there will be no controlling shareholder and actual controller after the change of equity.
Harbin Intelligent: The controlling shareholder signed an agreement of intent to transfer equity
Hagong Intelligent (000584) announced on the evening of September 30 that the controlling shareholder, Wuxi Zhefang Hagong Intelligent Robot Investment Enterprise (Limited Partnership) (hereinafter referred to as "Wuxi Zhefang"), intends to transfer part of the company's shares held by it to Shanghai Strict Enterprise Endowment Technology Service Co., Ltd. (hereinafter referred to as "Strict Enterprise Endowment"), with a transfer ratio of not less than 5%. After the transfer of the above-mentioned shares, Wuxi Tetsufang irrevocably delegates the voting rights of the remaining shares of the company held by it to the strict enterprise endowment. The transaction may result in the change of the controlling shareholder of the Company from Wuxi Zhefang to strict enterprise endowment.
CENT: Won the bid for the construction of the terminal project of 476 million yuan
Sente Co., Ltd. (603098) announced on the evening of September 30 that it recently received a notice of winning the bid from Western Airport Group Co., Ltd., confirming that the company won the bid for the East Terminal Project and GTC Project Metal Roof Construction of the Phase III Expansion Project of Xi'an Xianyang International Airport. The winning bid amount is 476 million yuan, accounting for 15.15% of the company's operating income in 2021. The winning bid period is 338 days.
Qingshan Paper: plans to build an alkali recovery technical transformation project of 680 million yuan
Qingshan Paper (600103) announced on the evening of September 30 that the company intends to carry out technical transformation of the existing pulp alkali system and build an alkali recovery production line that processes 2,000 tons of solids per day, with a total investment of 680 million yuan. After the project is completed and put into operation, it will change the status quo of the company to determine the production of alkali, solve the problem of insufficient capacity of the alkali recovery system, and increase the output of pulp and paper.
Sugon: The listing of its subsidiary Sugon Digital Innovation on the North Stock Exchange was approved by the CSRC
Sugon (603019) announced on the evening of September 30 that its subsidiary Sugon Digital Creation applied for a public offering of shares and was listed on the Beijing Stock Exchange and obtained the approval of registration by the China Securities Regulatory Commission. The approval is valid for 12 months from the date of consent to registration. After the completion of the public offering, the company's shareholding in Sugon Digital Innovation will be reduced from 70% to 62%.
Pingmei shares: Proposed to purchase production capacity indicators from China Pingmei Shenma Group
Pingmei Co., Ltd. (601666) announced on the evening of September 30 that in order to enhance the company's coal production capacity, the company intends to purchase 2.045 million tons / year capacity replacement index from the controlling shareholder China Pingmei Shenma Group, with a total transaction amount of 241 million yuan (including tax), mainly for the company's subordinate Henan Pingbao Coal Industry Co., Ltd. Shoushan No. 1 Mine Renovation and Expansion Project and the construction of the No. 2 Well, the Second Mine, the Fourth Mine and the Eleven Mine of the Eighth Mine No. 2 Well, the Second Mine and the Eleventh Mine to build new coal production capacity.
Hekeda: Ruihecheng Holdings intends to transfer 5% of the company's shares to Zhongyue Tiancheng
Hekeda (002816) announced on the evening of September 30 that Yiyang Ruihecheng Holdings Co., Ltd. intends to transfer 5% of the company's shares held by it to Shenzhen Qianhai Zhongyue Tiancheng Investment Partnership (Limited Partnership) for a transfer price of 125 million yuan and a price of 25 yuan per share. After the completion of the transfer, Zhongyue Tiancheng holds 5% of the company's shares, and Ruihecheng Holdings holds 7.24% of the company's shares.
Paging shares: plans to invest no more than 1.8 billion yuan in the construction of a new generation of photovoltaic junction boxes, chip module projects
Tongling Co., Ltd. (301168) announced on the evening of September 30 that the company intends to sign the "New Generation of Photovoltaic Junction Box and Chip Module Project Investment Contract" with the Administrative Committee of Jiangsu Dafeng Economic Development Zone, and the company intends to raise funds and self-owned or self-raised funds through its wholly-owned subsidiary Jiangsu Tongtong New Energy Co., Ltd. to raise funds and self-owned or self-raised funds of no more than 1.8 billion yuan to invest in the construction of a new generation of photovoltaic junction boxes and chip module projects.
Tuojing Technology: Plans to invest in the construction of semiconductor advanced technology equipment research and development and industrialization projects
Tuojing Technology (688072) announced on the evening of September 30 that it intends to invest in the research and development and industrialization of semiconductor advanced process equipment, with a total investment of 930 million yuan. The Company intends to use the over-raised funds of RMB930 million from the initial public offering of shares and listing on the Star Market to invest in the project.
BIOTEC: BAT1806 injection application for marketing authorization in the European EMA was accepted
BIOTEC (688177) announced on the evening of September 30 that the company submitted an application for the listing of biological products of BAT1806 (tocilizumab) injection to the European Medicines Agency, and recently received a notice of acceptance by the European EMA.
Oriental Network: Proposed to change the company name and securities abbreviation
Oriental Network (002175) announced on the evening of September 30 that one of the company's original main businesses, the network media business, has been basically divested, and the company intends to change the company name and securities abbreviation, the changed company name is "Guangxi Oriental Intelligent Manufacturing Technology Co., Ltd.", and the changed securities are referred to as "Oriental Intelligent Manufacturing". In addition, the Company intends to increase the capital of Guilin Guanglu Digital Measurement and Control Co., Ltd., a wholly-owned subsidiary, by 396 million yuan by means of debt-to-equity swap.
Guangdong Hydropower: Won the bid for a construction project of 1.075 billion yuan
Guangdong Hydropower (002060) announced on the evening of September 30 that the company won the bid for the "Hanjiang Rongjiang Lianjiang River Water System Connection Follow-up Optimization Project Construction 4 Bids" project, with a winning bid price of 1.075 billion yuan.
Agricultural products: The Shanghai subsidiary intends to waive the rent of the merchants for no more than 6 months
Agricultural Products (000061) announced on the evening of September 30 that Shanghai Agricultural Products Center Wholesale Market Operation and Management Co., Ltd., a holding subsidiary, intends to waive the rent of no more than 6 months for small and micro enterprises, individual industrial and commercial households and natural persons who lease state-owned houses (for operation) in the Shanghai Agricultural Products Center Wholesale Market. According to preliminary calculations, the implementation of preferential measures is expected to have an impact of about 70 million yuan on the company's total profits.
Fulin Transportation: The transfer of the equity of Mianyang Commercial Bank was not solicited by the transferee
Fulin Transportation (002357) announced on the evening of September 30 that the company had previously announced that it intended to transfer its 6.545% equity interest in Mianyang City Commercial Bank Co., Ltd. by way of public solicitation of intended transferees. As of now, the public solicitation period has expired, the company has not solicited suitable transferees, and the public solicitation has been terminated. The Company will find another suitable counterparty to continue to promote the above-mentioned equity transfer.
Visualization Technology: Identified as a state-level specialized new "little giant" enterprise
Visualization Technology (301213) announced on the evening of September 30 that the company was identified as a national-level specialized new "little giant" enterprise, valid for three years.
Tiantie Co., Ltd.: Signed a sales contract for rubber floating panels of 31.48 million yuan
Tiantie Co., Ltd. (300587) announced on the evening of September 30 that recently, the company signed the "Rubber Floating Board Procurement Contract" with the buyer China Railway Material and Trade Group Co., Ltd. Rail Integration Branch and the supervisor China Railway City Development and Investment Group Co., Ltd. Chengdu Rail Transit Engineering Command, with a contract amount of 31.4847 million yuan.
King Kong Glass: The abbreviation of the securities will be changed to "King Kong Photovoltaics" from October 10
Diamond Glass (300093) announced on the evening of September 30 that after the application of the company and the approval of the Shenzhen Stock Exchange, since October 10, the company's full name has been changed from "Gansu Diamond Glass Technology Co., Ltd." to "Gansu Diamond Photovoltaic Co., Ltd.", and the company's securities abbreviation has been changed from "Diamond Glass" to "Diamond Photovoltaic".
China Resources 39: Plans to participate in Yibao Technology to lay out the Huimin Insurance Track
China Resources 39 (000999) announced on the evening of September 30 that the company intends to increase the capital of Yibao Technology (Shanghai) Co., Ltd. together with the controlling shareholders China Resources Pharmaceutical Holdings and China Resources Yao Health. The company intends to invest 18.3 million yuan and hold 3.0148% of the equity of Yibao Technology; China Resources Pharmaceutical Holdings and China Resources Yao Health intend to invest 24.4 million yuan and 18.3 million yuan respectively, holding 4.0198% and 3.0148% of the equity of Yibao Technology respectively. Yibao Technology is a service provider of urban Huimin Insurance platform, and China Resources 39 participates in Yibao Technology, which can lay out the Huimin Insurance track in advance and build a bridge for cooperation with Baoshi.
Friendship Group: Terminate the operation of Friendly Fashion Shopping City
Friendship Group (600778) announced on the evening of September 30 that due to the continuous loss of the company's leasing and operation of the friendly fashion shopping city project, the company and the project lessor Xinjiang Shangpin Commercial Management Co., Ltd. reached an agreement to terminate the leasing operation of the friendly fashion shopping city project in advance on September 30. The company will pay compensation of 24.2397 million yuan to the lessor, thereby reducing the company's net profit attributable to the shareholders of the listed company in 2022 by 24.2397 million yuan.
This article originates from the financial world
![Asian Championships: 2 golds, 3 silvers and 7 bronzes in the national feathers, Zhang Shuxian cried bitterly! Asian Games men's singles champion 2-0! Indonesia 1 gold[fig]](data:image/gif;base64,R0lGODlhAQABAIAAAP///wAAACwAAAAAAQABAAACAkQBADs=)